对可植入左心室辅助装置的审查
Eiki Tayama1, Kazuyoshi Takagi1, Takahiro Shojima1
1Division of Cardiovascular Surgery, Department of Surgery, Kurume University School of Medicine.
The Kurume medical journal
|June 14, 2023
概括
左心室辅助器件 (LVAD) 已经从脉动到连续流动和磁悬浮设计,改善心力衰竭治疗. 持续的开发旨在提高可靠性,并扩大目的地治疗的使用范围.
科学领域:
- 心血管医学 心血管医学
- 生物医学工程 生物医学工程
- 医疗器械 医疗器械
背景情况:
- 严重的心力衰竭需要机械循环支持.
- 整体人工心脏的开发一直没有成功,但左心室辅助器件 (LVAD) 已经取得了显著的进步.
- LVAD已经从体外系统转向植入式系统.
研究的目的:
- 审查可植入左心室辅助器件 (LVAD) 的演变.
- 要突出与LVAD技术相关的临床益处和持续挑战.
- 讨论LVAD开发的未来方向,包括目的地治疗.
主要方法:
- 审查LVADs的历史发展和技术进步.
- 对不同LVAD代相关的临床结果和益处的分析.
- 讨论机械循环支的当前局限性和未来研究轨迹.
主要成果:
- 第一代脉动性LVAD改善了桥梁到移植的生存率和日常生活.
- 第二代连续流装置 (轴向和离心) 减少了机械故障和设备尺寸.
- 第三代设备具有磁性或液压动力学悬挂的螺旋,提高了可靠性和耐用性.
结论:
- 多代LVAD技术取得了进步,为心力衰竭患者提供了显著的临床优势.
- 尽管有了改进,但与设备相关的并发症仍然存在,需要在设备设计和患者管理方面进一步创新.
- 预计未来的发展将为更广泛的应用,包括目的地治疗,增强可植入LVAD.
相关概念视频
Cardiomyopathy V: Interprofessional Care
18
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18
Heart Failure VI: Adjunct Therapies
17
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
17
Cardiac Catheterization III: Left Heart Catheterization
87
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
87
Mitral Regurgitation III: Medical Management
20
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
20
Mitral Valve Prolapse II: Assessment and Management
23
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
23
Heart Failure V: Medical Management
16
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
16


